Investment Press Release
hemotune makes a significant step forward: advancing into clinical trials after completing CHF 14 million Series B2 round
Liestal, Switzerland, September 2023 – HEMEX, a bench-to-market clinical Contract Research Organization (CRO) announces the [...]
Continue reading
Diversity Hemex Team
We welcome David to the team!
HEMEX contribution for preparing tomorrow's leaders!
Continue reading
Investment Press Release
Driving the future of non-surgical endometriosis diagnosis: Hera Biotech acquires Scailyte’s endometriosis diagnostic assets
Liestal, Switzerland, September 2023 – HEMEX, a bench-to-market clinical Contract Research Organization (CRO) announces the [...]
Continue reading
Hemex Team
Graphic Design Internship at HEMEX
Noémie is a student at FMS Muttenz. She completed a two-week internship at HEMEX focusing [...]
Continue reading
Hemex Team Press Release
HEMEX opens subsidiary in Belgium, expanding its presence in the EU
Liestal, Switzerland, September 2023 – HEMEX, a bench-to-market clinical Contract Research Organization (CRO) announces the [...]
Continue reading
The W.A. de Vigier Award is the oldest and highest endowed prize for startups in Switzerland, giving away five awards of CHF 100’000 each. Applications are open until January 6th. Since 1989, the foundation has distributed over CHF 11 million of seed money, resulting in more than 90 thriving Swiss startups, successful IPOs, multiple company […]
The HEMEX team participated in a workshop organized by AMT Medical at the UMC Utrecht (Netherlands) in the first week of December. A team of world-renowned cardiac surgeons demonstrated the application of AMT’s ELANA (Excimer Laser Assisted Non-occlusive Anastomosis) Heart Bypass System on a beating porcine heart on LifeTec’s innovative cardiac simulator platform. The ELANA […]
On 14th November 2019, our CEO Pascal Winnen signed a cooperation agreement with the Luoyang Science and Innovation Park in Henan, China’s most populated province. Under the Agreement, HEMEX will support the property developer Forton Group with attracting innovative Swiss startups for its newly built 133’000 m2 life science park. In exchange, HEMEX and its […]
The European Commission has awarded a consortium led by AMT Medical including HEMEX with a 2.2 MEUR grant under its “Fast-Track to Innovation (FTI)” program. Under the proposal HEMEX will plan, coordinate and execute a multicentric, pan-European study in order to obtain CE-mark for the Excimer Laser Assisted Non-occlusive Anastomosis (ELANA) Heart Bypass System in Patients […]